Kala Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.44

+0.04 (+10.28%)

As of Feb 8, 2:28 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +2,443.2% upside

Low Target $8.32

Average Target $11.19

High Target $14.48

Current Price $0.44

Current
$0.44

Target
$11.19

$8.32 $11.19 avg $14.48

Scenario Analysis

Bear Case

$8.32

1,790.9%

Low target

Base Case

$11.19

+2,443.2%

Avg target

Bull Case

$14.48

+3,190.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$15.68

-97.2% from high

52-Week Low

$6.35

+-93.1% from low

Target vs 52W High

$11.19

-28.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%